QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 merrimack-pharmaceuticals-announces-approval-of-plan-of-dissolution-and-cash-liquidating-dividend-amount-of-1510-per-share

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) ("Merrimack" or the "Company") announced that the stockholders at...

Core News & Articles

The company has received a $225 million payment which was due from Ipsen, S.A. as a result of its receipt of approval from the ...

Core News & Articles

Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde® regimen (NALIRIFOX) demonstrated statistically significan...

Core News & Articles

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-irinotecan-liposome-first-line-treatment-metastatic...

 2m-bet-on-ford-check-out-these-4-stocks-insiders-are-buying

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

 merrimack-pharmaceuticals-q3-eps-002-up-from-003-yoy

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.02) per share. This is a 33.33 percent increase over l...

 merrimack-pharmaceuticals-q2-eps-003-up-from-004-yoy

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over loss...

 merrimack-pharmaceuticals-q1-eps-002-down-from-001-yoy

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over los...

 why-jounce-therapeutics-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Gainers

 luna-innovations-guess-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

 merrimack-pharmaceuticals-fy22-eps-011-vs-018-yoy

Full Year 2022 Financial Results Merrimack reported net loss of $1.5 million for the year ended December 31, 2022, or $0.11 pe...

 3-stocks-insiders-are-buying-triumph-financial-and-more

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

 26m-bet-on-this-energy-stock-check-out-these-3-stocks-insiders-are-buying

Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.

 insiders-buying-heska-b-riley-financial-and-2-other-stocks

Although US stocks closed mixed on Monday, there were a few notable insider trades.

 14-million-bet-on-joint-corp-check-out-these-3-stocks-insiders-are-buying

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION